Hims & Hers (HIMS) Stock Lawsuits: Investors Urged to Act - Hagens Berman

SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Investors who lost money in Hims & Hers (NYSE: HIMS) are being urged to actively participate in a securities class action lawsuit. The lawsuit alleges that Hims made misleading statements about its GLP-1 weight-loss drug business and its partnership with Novo Nordisk, which was abruptly canceled. This comes after Hims stock plummeted by over 34% on June 23, 2025, when Novo Nordisk ended the collaboration, citing Hims’ “deceptive promotion and selling of illeg ...